Modus Therapeutics Holding AB (FRA:99Z) Other Operating Expense : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB Other Operating Expense?

Modus Therapeutics Holding AB's Other Operating Expense for the three months ended in Mar. 2025 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

Modus Therapeutics Holding AB's quarterly Other Operating Expense declined from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€0.00 Mil) and declined from Dec. 2024 (€0.00 Mil) to Mar. 2025 (€-0.00 Mil).

Modus Therapeutics Holding AB's annual Other Operating Expense declined from Dec. 2022 (€0.01 Mil) to Dec. 2023 (€0.01 Mil) and declined from Dec. 2023 (€0.01 Mil) to Dec. 2024 (€0.00 Mil).

Modus Therapeutics Holding AB Other Operating Expense Historical Data

The historical data trend for Modus Therapeutics Holding AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modus Therapeutics Holding AB Other Operating Expense Chart

Modus Therapeutics Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

0.01

Modus Therapeutics Holding AB Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Modus Therapeutics Holding AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Modus Therapeutics Holding AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Modus Therapeutics Holding AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Modus Therapeutics Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (FRA:99Z) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

MODTX:Sweden

Address

Olof Palmes gata 29 IV, Stockholm, SWE, 111 22

Website

https://www.modustx.com

Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB Headlines

No Headlines